UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Journal of clinical oncology, 2005-12, Vol.23 (34), p.8636-8645

2005

Volltextzugriff (PDF)

Role of anthracyclines in the era of targeted therapy

Cardiovascular toxicology, 2007-06, Vol.7 (2), p.56-60

2007

Volltextzugriff (PDF)

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

Cancer, 2002-08, Vol.95 (4), p.751-757

2002

Volltextzugriff (PDF)

Long-Term Follow-Up of an Anthracycline-Containing Metronomic Chemotherapy Schedule in Advanced Breast Cancer

The breast journal, 2009-09, Vol.15 (5), p.551-553

2009

Volltextzugriff (PDF)

Chemotherapy for cholangiocarcinoma:An update

World journal of gastrointestinal oncology, 2013-07, Vol.5 (7), p.171-176

Natalia Ramírez-Merino Santiago Ponce Aix Hernán Cortés-Funes

2013

Volltextzugriff (PDF)

Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221086911-17588359221086911

2022

Volltextzugriff (PDF)

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

Clinical cancer research, 2009-01, Vol.15 (1), p.307-314

2009

Volltextzugriff (PDF)

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

Cancer, 2004-06, Vol.100 (11), p.2462-2469

2004

Volltextzugriff (PDF)

Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial

JNCI : Journal of the National Cancer Institute, 2001-01, Vol.93 (1), p.31-38

2001

Volltextzugriff (PDF)

Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy

American journal of clinical oncology, 2009-08, Vol.32 (4), p.375-380

2009

Volltextzugriff (PDF)

Breast Cancer–Specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-Risk Breast Cancer Patients Treated With High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3611-3618

2006

Volltextzugriff (PDF)

The role of antiangiogenesis therapy: Bevacizumab and beyond

Clinical & translational oncology, 2009-06, Vol.11 (6), p.349-355

Cortés-Funes, Hernán

2009

Volltextzugriff (PDF)

The Role of RANK‐Ligand Inhibition in Cancer: The Story of Denosumab

The oncologist (Dayton, Ohio), 2011-02, Vol.16 (2), p.136-145

2011

Volltextzugriff (PDF)

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Cancer and metastasis reviews, 2010-12, Vol.29 (4), p.751-759

2010

Volltextzugriff (PDF)

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5568-5577

2005

Volltextzugriff (PDF)

Phase II trial of dose‐dense paclitaxel, cisplatin, 5‐fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

Cancer, 2004-08, Vol.101 (4), p.768-775

2004

Volltextzugriff (PDF)

Incidence of Contralateral Germ Cell Testicular Tumors in South Europe:: Report of the Experience at 2 Spanish University Hospitals and Review of the Literature

The Journal of urology, 2004, Vol.171 (1), p.164-167

2004

Volltextzugriff (PDF)

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer

Journal of cancer research and clinical oncology, 2015-01, Vol.141 (1), p.43-53

2015

Volltextzugriff (PDF)

Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma

Cancer, 2004-05, Vol.100 (9), p.1833-1842

2004

Volltextzugriff (PDF)

Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: A brief report on a Spanish cohort

Psycho-oncology (Chichester, England), 2003-12, Vol.12 (8), p.821-827

2003

Volltextzugriff (PDF)

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer

Tumor biology, 2015-02, Vol.36 (2), p.1199-1206

2015

Volltextzugriff (PDF)

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

Clinical & translational oncology, 2011-03, Vol.13 (3), p.179-184

2011

Volltextzugriff (PDF)

Circulating HER2 Extracellular Domain and Resistance to Chemotherapy in Advanced Breast Cancer

Clinical cancer research, 2000-06, Vol.6 (6), p.2356-2362

2000

Volltextzugriff (PDF)

Prognostic value of KIT expression in small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2007-06, Vol.56 (3), p.405-413

2007

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(147)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(96)
Science & Technology
(96)
Humans
(94)
Oncology
(89)
Female
(73)
Middle Aged
(58)
Adult
(50)
Aged
(49)
Biological And Medical Sciences
(46)
Male
(46)
Medical Sciences
(46)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(34)
Chemotherapy
(26)
Tumors
(24)
Breast Neoplasms - Pathology
(23)
Pharmacology. Drug Treatments
(23)
Prognosis
(23)
Breast Neoplasms - Drug Therapy
(21)
Treatment Outcome
(21)
Aged, 80 And Over
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer

Role of anthracyclines in the era of targeted therapy

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

Long-Term Follow-Up of an Anthracycline-Containing Metronomic Chemotherapy Schedule in Advanced Breast Cancer

Chemotherapy for cholangiocarcinoma:An update

Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies

Decreased immunoreactivity for p27 protein in patients with early-stage Breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status results from International Breast Cancer Study group Trial V

Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study

Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia

Granulocyte Colony-Stimulating Factor in the Treatment of High-Risk Febrile Neutropenia: a Multicenter Randomized Trial

Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy

Breast Cancer–Specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-Risk Breast Cancer Patients Treated With High-Dose Chemotherapy With Peripheral Blood Stem Cell Support

The role of antiangiogenesis therapy: Bevacizumab and beyond

The Role of RANK‐Ligand Inhibition in Cancer: The Story of Denosumab

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase II trial of dose‐dense paclitaxel, cisplatin, 5‐fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

Incidence of Contralateral Germ Cell Testicular Tumors in South Europe:: Report of the Experience at 2 Spanish University Hospitals and Review of the Literature

Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer

Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma

Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: A brief report on a Spanish cohort

Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

Circulating HER2 Extracellular Domain and Resistance to Chemotherapy in Advanced Breast Cancer

Prognostic value of KIT expression in small cell lung cancer

Suchergebnisse filtern